Alnylam Pharmace. buy Raymond James
Start price
28.09.23
/
50%
€166.00
Target price
28.09.24
-
Performance (%)
46.20%
End price
29.09.24
€242.70
Summary
This prediction ended on 29.09.24 with a price of €242.70. The BUY prediction by Raymond_James for Alnylam Pharmace. saw massive gains of 46.20%. Raymond_James has a follow-up prediction for Alnylam Pharmace. where he still thinks Alnylam Pharmace. is a Buy. Raymond_James has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Alnylam Pharmace. | -0.651% | -0.651% | 23.205% |
| iShares Core DAX® | -1,10 % | -6,08 % | 3,20 % |
| iShares Nasdaq 100 | 0,33 % | 2,33 % | 20,24 % |
| iShares Nikkei 225® | -1,08 % | -7,99 % | 27,55 % |
| iShares S&P 500 | -0,06 % | 0,88 % | 14,89 % |
Comments by Raymond_James for this prediction
In the thread Alnylam Pharmace. diskutieren
Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY) is now covered by analysts at Raymond James. They set an "outperform" rating on the stock.
Ratings data for ALNY provided by MarketBeat
In the thread Trading Alnylam Pharmace.
Die von Raymond_James gewählte maximale Laufzeit wurde überschritten
Current prediction by Raymond_James for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€295.00
30.07.25
30.07.25
€319.87
30.07.26
30.07.26
-6.95%
13.03.26
13.03.26
Stopped prediction by Raymond_James for Alnylam Pharmace.
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€254.50
01.11.24
01.11.24
€274.85
01.11.25
01.11.25
54.18%
02.11.25
02.11.25
Alnylam Pharmace.
Start price
Target price
Perf. (%)
€247.40
02.08.24
02.08.24
€251.93
02.08.25
02.08.25
38.64%
03.08.25
03.08.25